The seeding efficiency of normal and hereditarily anemic (b/b) rat bone marrow colony forming units-spleen as determined in a "rat to mouse" assay

Stem Cells
Z Ivanovíc, P Milenkovíc

Abstract

We demonstrated recently a decreased number, concentration and proliferative activity of colony forming units-spleen day 8 (CFU-Sd8) in the bone marrow of the hereditarily anemic Belgrade Laboratory (b/b) rat. The main consequence of the genetic defect in the b/b rat is impaired intracellular transport of iron resulting in altered hemopoietic stem and progenitor cell compartments. In this study, the seeding efficiency (f) for normal and b/b rat bone marrow CFU-Sd8 was determined in a "rat to mouse" CFU-S assay. There were no differences in f values for normal and b/b rat bone marrow CFU-Sd8, indicating that the severe anemia and consequent metabolic alterations did not affect f in the b/b rat. The calculation of CFU-Sd8 concentration per 10(5) normal rat bone marrow cells using f as a correction factor revealed a value similar to that found for populations of bone marrow cells defined by phenotypes Ox7+ (20%), Ox22-, W3/13dim, considered to be characteristic of CFU-S. The results revealed the usefulness of the "rat to mouse" assay for the determination of rat hemopoietic stem cells.

References

Jan 1, 1976·Cell and Tissue Kinetics·A VacekL Tkadlecek
May 1, 1990·International Journal of Cell Cloning·K F McCarthy, M L Hale
Aug 1, 1973·Australian and New Zealand Journal of Medicine·K A RickardH Kronenberg
Dec 1, 1963·Journal of Cellular Physiology·L SIMINOVITCHJ E TILL

❮ Previous
Next ❯

Citations

Nov 17, 2001·International Immunopharmacology·D K AgrawalJ E Talmadge
Jun 9, 1998·Stem Cells·D L GreinerL D Shultz
Oct 19, 2010·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·Vundavilli Jagadeesh KumarK Mukkanti
Aug 5, 2005·Chemical & Pharmaceutical Bulletin·Tomoko FujimotoKakuji Tojo
May 3, 2007·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Yasuhiko Tabata
Jan 12, 2008·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·Tsuyoshi TsurutaTerufumi Fujiwara
Jan 12, 2008·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·Shin-Ichi Tate
Jan 12, 2008·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·Kousuke Kurisaki, Kazuhisa Yoshimura
Feb 2, 2008·World Journal of Gastroenterology : WJG·Jing ZhouShan-Miao Gou
Mar 12, 2008·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·Hiroo Isagai
Mar 12, 2008·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·Takashi MasadomeToshiaki Hattori
Apr 12, 2008·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·Toshiaki Hattori, Kazuhito Katai
Jun 6, 2008·World Journal of Gastroenterology : WJG·Dimitrios-P BogdanosDiego Vergani
Jun 12, 2008·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·Naoki SurugayaMasaru Watahiki
Jun 12, 2008·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·Longfei Cai, Chunxiu Xu
Mar 12, 2009·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·Per WiklundMartina Levin
Feb 11, 2010·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·Yoichiro FurukawaAkihiro Tanaka

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.